Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01892371
Title Quizartinib With Azacitidine or Cytarabine in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

chronic myeloid leukemia

myelodysplastic syndrome

acute myeloid leukemia


Azacitidine + Quizartinib

Cytarabine + Quizartinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST